-
Antibody-drug conjugates
Non-cleavable linkers for ADCs
Different linker chemistry approaches have been developed since the inception of ADCs. Currently, cleavable and non-cleavable linkers are the most well-established each with its particular challenges and advantages. Substantially…
-
CAR-T cell therapy
From the first to the fifth generation of CAR-T cells
Read more -
CAR-T cell therapy
The structure of CAR-T cells
Read more -
Antibody-drug conjugates
Robust methods for the detailed analysis of drug-to-antibody ratio (DAR) and drug load distribution
Read more -
Antibody-drug conjugates
ADC payloads
Read more -
Antibody production
What are chimeric antibodies?
Read more
-
Antibody production
Overcoming the Hurdles of Antibody Production and Scale-Up
Read more -
Antibody production
How To Improve The Yield Of Your Antibody Production?
Read more -
Antibody production
How Can Single B Cell Sorting Propel Your Antibody Discovery to New Heights?
Read more -
Antibody production
Harness the Power of Single B Cell Antibody Technologies for Advanced Antibody Development
Read more -
Antibody production
Is Your Antibody Development Taking Too Long? Speed It Up with These Tips!
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
Read more -
Antibody production
Reinventing IgY biotherapeutics
Read more -
Antibody production
How the environment shapes immune system development during pregnancy
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Read more